We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sharp Decline Seen in Use of Cardiac Nuclear Myocardial Perfusion Imaging

By HospiMedica International staff writers
Posted on 15 Apr 2014
There has been a substantial decrease in the use of nuclear myocardial perfusion imaging (MPI) since 2006, an imaging modality used to detect areas of the heart with decreased blood flow, a decline that cannot be justified by an increase in other imaging methods, according to recent findings.

The new findings were published March 26, 2014, in the Journal of the American Medical Association (JAMA). More...
Nuclear MPI accounted for much of the rapid growth in cardiac imaging that occurred from the 1990s through the middle 2000s. Edward J. McNulty, MD, from Kaiser Permanente Medical Center (San Francisco, CA, USA) and colleagues conducted a study to examine trends in MPI use within a large, community-based population. They gathered patient data for MPI performed from 2000–2011 for members ages 30 years or older from the clinical databases of Kaiser Permanente Northern California, an integrated healthcare delivery system that provides inpatient and outpatient care for more than 2.3 million adults.

Overall, MPI was used to treat 302,506 patients at 19 facilities. MPI use from 2000 until 2006 increased by a comparative 41%, but between 2006 and 2011, MPI use declined a relative 5%. Declines from 2006 to 2011 were greater for outpatients than inpatients (58% vs. 31%) and for persons younger than 65 years. Use of cardiac computed tomography (CT), a newer imaging technology, increased during this time period, and could have accounted for 5% of the observed decline in overall MPI use if performed as an option.

“Although the abrupt nature of the decline suggests changing physician behavior played a major role, incident coronary disease, as assessed by [heart attack], also declined [by 27%]. We could not determine the relative effects of these factors on MPI use,” the authors wrote. “...the substantial reduction in MPI use demonstrates the ability to reduce testing on a large scale with anticipated reductions in healthcare costs.”

Related Links:

Kaiser Permanente Medical Center


Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Monitor/Defibrillator
Zenix
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Sphere-9 is the first all-in-one mapping and ablation, large-tip focal, dual-energy catheter to be CE marked for ventricular ablation (Photo courtesy of Medtronic)

Dual-Energy Mapping and Ablation Catheter Receives CE Mark for Ventricular Arrhythmias

Ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes, can be life-threatening and often occur in patients with advanced heart disease. Although catheter ablation... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.